Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
4.445
+0.035 (0.79%)
Nov 21, 2024, 2:40 PM EST - Market open
Humacyte Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
185
Market Cap
572.57M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 1.57M | 302.00K | 23.91% |
| Dec 31, 2021 | 1.26M | -228.00K | -15.29% |
| Dec 31, 2020 | 1.49M | -4.70M | -75.90% |
| Dec 31, 2019 | 6.19M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Varex Imaging | 832.70M |
| Axogen | 180.86M |
| Surmodics | 126.08M |
| Butterfly Network | 76.22M |
| CureVac | 70.57M |
| Simulations Plus | 70.01M |
| AnaptysBio | 57.17M |
HUMA News
- 1 day ago - The Schall Law Firm Urges Shareholder Participation In A Securities Fraud Case Against Humacyte Inc - Accesswire
- 1 day ago - Rosen Law Firm Urges Humacyte, Inc. (NASDAQ: HUMA) Stockholders with Large Losses in Excess of $100K to Contact the Firm for Information About Their Rights - Business Wire
- 6 days ago - Humacyte's (HUMA) Statements to Investors Called Into Question in Light of FDA Violations – Hagens Berman - GlobeNewsWire
- 6 days ago - Humacyte, Inc. (HUMA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Accesswire
- 7 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages Humacyte, Inc. (HUMA) Shareholders to Inquire about Securities Investigation - Accesswire
- 8 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Humacyte, Inc. (HUMA) And Encourages Shareholders to Connect - Accesswire
- 9 days ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Humacyte, Inc. (HUMA) And Encourages Shareholders to Reach Out - Accesswire
- 9 days ago - Humacyte (HUMA) Faces Questions After FDA Inspection – Hagens Berman - GlobeNewsWire